While most patients remained on AOM tirzepatide, 8.0% switched to AOM semaglutide during this period
Diabetologia 53 , 153159 (2010)
Depending on the type of insulin you use, it may work quickly, slowly, or across the entire day
Details on our semaglutide page
Tirzepatide, a dual GIP/GLP-1 receptor agonist approved for diabetes management and weight loss, works through distinct mechanisms from testosterone replacement therapy (TRT), which restores physiological hormone levels in men with confirmed low testosterone
TGF beta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation